Archer-Daniels-Midland's cost discipline drives earnings recovery through 2026. Read here to know why we recommend a Buy on ...

In sleep-deprived Japan, designers have created the ZZZN Sleep Aparrel System — a puffer jacket concept that doubles as an on ...

CSX stock rated 'Buy' with $38 PT. Discover margin growth, capital efficiency, and 14% upside as cost pressures ease.

Now that Ultomiris has matched the indications of its predecessor Soliris, AstraZeneca is eyeing new avenues for the C5 drug ...

Incyte's INCA033989 showed early efficacy and strong tolerability in essential thrombocythemia patients with mutCALR, ...